Xencor (XNCR) PT Raised to $22 at Wedbush as '5871 and '7195 Demonstrate Clinical Activity
Tweet Send to a Friend
Wedbush analyst David Nierengarten boosted his price target on Outperform-rated Xencor, Inc. (NASDAQ: XNCR) to $22.00 (from $18.00) after first ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
